The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant anti–PD-1 prolgolimab monotherapy in resectable high-risk melanoma: Pathologic response and early event-free survival in a prospective single-arm phase II CRISTINA study.
 
Angelina Kuzmenko
No Relationships to Disclose
 
Igor Samoylenko
Honoraria - BioCad; Novartis; Pierre Fabre; R-Pharm; Roche; Swixx BioPharma
Speakers' Bureau - BioCad; Novartis; Pierre Fabre; R-Pharm; Roche; Swixx BioPharma
Research Funding - BioCad (Inst); CureVac (Inst); Gene Surgery (Inst); Novartis (Inst); R-Pharm (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BioCad; Roche
 
Yana Vishnevskaya
No Relationships to Disclose
 
Viktoriya Prokopenko
No Relationships to Disclose
 
Viktoriya Aginova
No Relationships to Disclose
 
Galina Kharkevich
No Relationships to Disclose
 
Kirill Baryshnikov
No Relationships to Disclose
 
Lev Demidov
No Relationships to Disclose